Log in

NYSE:CLSCelestica Stock Price, Forecast & News

+0.21 (+3.04 %)
(As of 06/3/2020 04:00 PM ET)
Today's Range
Now: $7.11
50-Day Range
MA: $5.60
52-Week Range
Now: $7.11
Volume337,694 shs
Average Volume640,056 shs
Market Capitalization$917.55 million
P/E RatioN/A
Dividend YieldN/A
Celestica Inc. provides design, manufacturing, hardware platform, and supply chain solutions in Canada and internationally. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing, assembly and test, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It serves the aerospace and defense, industrial, smart energy, healthtech, capital equipment, enterprise communications, telecommunications, servers, and storage businesses. The company was incorporated in 1996 and is headquartered in Toronto, Canada.
Read More
Celestica logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars

Industry, Sector and Symbol

Industry Printed circuit boards



Sales & Book Value

Annual Sales$5.89 billion
Cash Flow$1.67 per share
Book Value$10.53 per share


Net Income$70.30 million


Market Cap$917.55 million
Next Earnings Date7/22/2020 (Estimated)

Receive CLS News and Ratings via Email

Sign-up to receive the latest news and ratings for CLS and its competitors with MarketBeat's FREE daily newsletter.

Celestica (NYSE:CLS) Frequently Asked Questions

How has Celestica's stock been impacted by COVID-19 (Coronavirus)?

Celestica's stock was trading at $5.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLS stock has increased by 40.2% and is now trading at $7.11. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Celestica?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celestica in the last year. There are currently 1 sell rating and 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Celestica.

When is Celestica's next earnings date?

Celestica is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Celestica.

How were Celestica's earnings last quarter?

Celestica Inc (NYSE:CLS) released its earnings results on Wednesday, April, 29th. The technology company reported $0.16 EPS for the quarter, topping the Zacks' consensus estimate of $0.11 by $0.05. The technology company had revenue of $1.32 billion for the quarter, compared to analysts' expectations of $1.25 billion. Celestica had a negative net margin of 0.40% and a positive return on equity of 2.31%. Celestica's revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the company posted $0.12 earnings per share. View Celestica's earnings history.

What price target have analysts set for CLS?

7 equities research analysts have issued 1 year price targets for Celestica's stock. Their forecasts range from $5.00 to $8.00. On average, they expect Celestica's stock price to reach $6.61 in the next twelve months. This suggests that the stock has a possible downside of 7.1%. View analysts' price targets for Celestica.

Has Celestica been receiving favorable news coverage?

News stories about CLS stock have trended very negative on Thursday, according to InfoTrie. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Celestica earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutCelestica.

Are investors shorting Celestica?

Celestica saw a increase in short interest in May. As of May 15th, there was short interest totaling 511,700 shares, an increase of 119.0% from the April 30th total of 233,700 shares. Based on an average daily volume of 666,800 shares, the short-interest ratio is currently 0.8 days. Approximately 0.5% of the shares of the company are sold short. View Celestica's Current Options Chain.

Who are some of Celestica's key competitors?

What other stocks do shareholders of Celestica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celestica investors own include Aurora Cannabis (ACB), Quantum (QTM), Ballard Power Systems (BLDP), Portland General Electric (POR), NVIDIA (NVDA), AT&T (T), Netflix (NFLX), Shopify (SHOP), Walt Disney (DIS) and Freeport-McMoRan (FCX).

Who are Celestica's key executives?

Celestica's management team includes the following people:
  • Mr. Robert Andrew Mionis, Pres, CEO & Director (Age 56)
  • Mr. Mandeep Chawla, Chief Financial Officer (Age 42)
  • Mr. Todd Cooper, Chief Operations Officer (Age 49)
  • Mr. Michael P. McCaughey, Advisor (Age 57)
  • Mr. John Joseph Lawless, Pres of Advanced Technology Solutions (Age 58)

What is Celestica's stock symbol?

Celestica trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLS."

Who are Celestica's major shareholders?

Celestica's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (5.10%), Donald Smith & CO. Inc. (2.68%), Russell Investments Group Ltd. (2.53%), Morgan Stanley (2.50%), Morgan Stanley (2.50%) and Hillsdale Investment Management Inc. (2.26%).

Which major investors are selling Celestica stock?

CLS stock was sold by a variety of institutional investors in the last quarter, including Guardian Capital LP, Janus Henderson Group PLC, Alberta Investment Management Corp, CIBC Asset Management Inc, Foundry Partners LLC, The Manufacturers Life Insurance Company , Wellington Management Group LLP, and Mackenzie Financial Corp.

Which major investors are buying Celestica stock?

CLS stock was bought by a variety of institutional investors in the last quarter, including Hillsdale Investment Management Inc., Acadian Asset Management LLC, Pzena Investment Management LLC, Morgan Stanley, Morgan Stanley, Scheer Rowlett & Associates Investment Management Ltd., 1832 Asset Management L.P., and Connor Clark & Lunn Investment Management Ltd..

How do I buy shares of Celestica?

Shares of CLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Celestica's stock price today?

One share of CLS stock can currently be purchased for approximately $7.11.

How big of a company is Celestica?

Celestica has a market capitalization of $917.55 million and generates $5.89 billion in revenue each year. The technology company earns $70.30 million in net income (profit) each year or $0.54 on an earnings per share basis. Celestica employs 24,600 workers across the globe.

What is Celestica's official website?

The official website for Celestica is www.celestica.com.

How can I contact Celestica?

Celestica's mailing address is 5140 YONGE STREET SUITE 1900, TORONTO A6, M2N 6L7. The technology company can be reached via phone at 416-448-2211 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.